- Home
- KTOS vs NXPLW Comparison
KTOS vs NXPLW Comparison
Compare KTOS & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTOS
- NXPLW
- Stock Information
- Founded
- KTOS 1994
- NXPLW N/A
- Country
- KTOS United States
- NXPLW United States
- Employees
- KTOS N/A
- NXPLW 166
- Industry
- KTOS Military/Government/Technical
- NXPLW Telecommunications Equipment
- Sector
- KTOS Industrials
- NXPLW Telecommunications
- Exchange
- KTOS Nasdaq
- NXPLW Nasdaq
- Market Cap
- KTOS N/A
- NXPLW N/A
- IPO Year
- KTOS 1999
- NXPLW N/A
- Fundamental
- Price
- KTOS $34.42
- NXPLW $0.16
- Analyst Decision
- KTOS Buy
- NXPLW
- Analyst Count
- KTOS 9
- NXPLW 0
- Target Price
- KTOS $33.00
- NXPLW N/A
- AVG Volume (30 Days)
- KTOS 2.1M
- NXPLW 6.4K
- Earning Date
- KTOS 05-07-2025
- NXPLW 03-31-2025
- Dividend Yield
- KTOS N/A
- NXPLW N/A
- EPS Growth
- KTOS N/A
- NXPLW N/A
- EPS
- KTOS 0.11
- NXPLW N/A
- Revenue
- KTOS $1,136,300,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- KTOS $15.11
- NXPLW N/A
- Revenue Next Year
- KTOS $14.30
- NXPLW N/A
- P/E Ratio
- KTOS $307.05
- NXPLW N/A
- Revenue Growth
- KTOS 9.56
- NXPLW 179.89
- 52 Week Low
- KTOS $17.76
- NXPLW $0.25
- 52 Week High
- KTOS $35.66
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- KTOS 63.57
- NXPLW N/A
- Support Level
- KTOS $31.48
- NXPLW N/A
- Resistance Level
- KTOS $34.53
- NXPLW N/A
- Average True Range (ATR)
- KTOS 1.48
- NXPLW 0.00
- MACD
- KTOS 0.16
- NXPLW 0.00
- Stochastic Oscillator
- KTOS 98.21
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.